Ginkgo Bioworks Holdings Inc

DNA

Company Profile

  • Business description

    Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

  • Contact

    27 Drydock Avenue
    8th Floor
    BostonMA02210
    USA

    T: +1 877 422-5362

    https://www.ginkgobioworks.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    485

Stocks News & Analysis

stocks

CBA earnings: Business lending powers on, but costs and credit bear watching

Our view after the bank reports first quarter earnings.
stocks

Apple earnings review: Revenue beats estimates as memory crunch threatens margins

Apple shares are trading at record highs after posting solid results.
stocks

Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil

We’re reducing our long-term revenue estimates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,204.5069.70-0.75%
CAC 408,368.917.550.09%
DAX 4026,749.9521.93-0.08%
Dow JONES (US)52,347.5550.460.10%
FTSE 10010,902.5639.470.36%
HKSE23,637.60370.95-1.55%
NASDAQ25,136.27229.82-0.91%
Nikkei 22561,142.35322.990.53%
NZX 50 Index14,173.6885.55-0.60%
S&P 5007,561.6730.73-0.40%
S&P/ASX 2009,082.2064.60-0.71%
SSE Composite Index3,634.3521.48-0.59%

Market Movers